Improved detection of melanoma antigen-specific T cells expressing low or high levels of CD8 by HLA-A2 tetramers presenting a Melan-A/MART-1 peptide analogue

International Journal of Cancer

Volumn 97, Issue 1, 2002, Pages 64-71

  Maeurer, Markus J ^a   Necker, Antje ^b   Salter, Russell D ^c   Castelli, Chiara ^d   Höhn, Hanni ^a   Karbach, Julia ^e   Freitag, Kirsten ^a   Neukirch, Claudia ^a   Knuth, Alexander ^e   Jäger, Elke ^e  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

^b Immunomics Operations   (France)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^d NATIONAL CANCER INSTITUTE   (Italy)

^e Medizinische Klinik II   (Germany)

Author keywords

CD8; HLA A2; Major histocompatibility complex class 1; Melan A MART 1; T cell receptor

Indexed keywords

CD8 ANTIGEN; EPITOPE; HLA A2 ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MELAN A; MELANOMA ANTIGEN; PEPTIDE DERIVATIVE; T LYMPHOCYTE RECEPTOR;

ANTIGEN BINDING; ANTIGEN DETECTION; ANTIGEN EXPRESSION; ANTIGEN PRESENTATION; ANTIGEN SPECIFICITY; ARTICLE; BINDING SITE; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNE RESPONSE; PRIORITY JOURNAL; T LYMPHOCYTE;

ANTIGENS, NEOPLASM; CD8-POSITIVE T-LYMPHOCYTES; CYTOKINES; CYTOTOXICITY, IMMUNOLOGIC; EPITOPES; FLOW CYTOMETRY; HLA-A2 ANTIGEN; HUMANS; MELANOMA; NEOPLASM PROTEINS; NEOPLASM STAGING; PROTEIN BINDING; RECEPTORS, ANTIGEN, T-CELL; TUMOR CELLS, CULTURED;

EID: 0036132044     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/ijc.1580     Document Type: Article

References (34)

1. Phenotypic analysis of antigen-specific T lymphocytes
2. HLA-peptide tetrameric complexes
3. Isolation of high avidity melanoma-reactive CTL from heterogeneous populations using peptide-MHC tetramers
4. + T cells in melanoma patients
5. Characterization of circulating T cells specific for tumor-associated antigens in melanoma patients
6. Oligoclonal expansions of CD8(+) T cells in chronic HIV infection are antigen specific
7. + T cells during the primary immune response to Epstein-Barr virus in vivo
8. Efficient detection and immunomagnetic sorting of specific T cells using multimers of MHC class I and peptide with reduced CD8 binding
9. Polymorphism in the alpha 3 domain of HLA-A molecules affects binding to CD8
10. A binding site for the T-cell co-receptor CD8 on the alpha 3 domain of HLA-A2
11. CD8 modulation of T-cell antigen receptor-ligand interactions on living cytotoxic T lymphocytes
12. The p561ck SH2 domain mediates recruitment of CD8/p561ck to the activated T cell receptor/CD3/zeta complex
13. T cell receptor and coreceptor CD8 alphaalpha bind peptide-MHC independently and with distinct kinetics
14. Qualitative and quantitative differences in T cell receptor binding of agonist and antagonist ligands
15. Identification of the immunodominant peptides of the MART-1 human melanoma antigen recognized by the majority of HLA-A2-restricted tumor infiltrating lymphocytes
16. A new gene coding for a differentiation antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas
17. + cytotoxic T lymphocytes
18. + T cells with enhanced functional characteristics: Implication for more effective immunotherapy
19. Optimal activation of tumor-reactive T cells by selected antigenic peptide analogues
20. Critical role for CD8 in binding of MHC tetramers to tcr: CD8 antibodies block specific binding of human tumor-specific MHC-peptide tetramers to TCR
21. Cytotoxic T lymphocytes define multiple peptide isoforms derived from the melanoma-associated antigen MART-1/Melan-A
22. TCR usage in CTLs recognizing melanoma/melanocyte antigens
23. Cytolytic T-cell clones define HLA-A2-restricted human cutaneous melanoma peptide epitopes
24. Monoclonal TCR mRNA transcripts are preferentially detected in the TCR variable alpha chain in CD8(+) T-lymphocytes: Implications for immunomonitoring
25. T-cell repertoire diversity and clonal expansions in normal and clinical samples
26. + repertoire during antiviral therapy
27. Critical role for CD8 in T cell receptor binding and activation by peptide/major histocompatibility complex multimers
28. + T cells in the thymus
29. CD8 expression allows T cell signaling by monomeric peptide-MHC complexes
30. Identification of epitope mimics recognized by CTL reactive to the melanoma/melanocyte-derived peptide MART-1(27-35)
31. + T-cell clones reactive to melanoma/melanocyte epitope MART1 (27-35)
32. CD8 independence and specificity of cytotoxic T lymphocytes restricted by HLA-Aw68.1
33. Specificity pockets for the side chains of peptide antigens in HLA-Aw68
34. Recognition by CD8 on cytotoxic T lymphocytes is ablated by several substitutions in the class I alpha 3 domain: CD8 and the T-cell receptor recognize the same class I molecule